Clinical trial

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

NCT00232661

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-08-01

PhasePHASE3

Study timeline

Study start (unknown)2000-08-01Date precision: month

Registry last updated2010-02-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

ARIMIDEX (anastrazole)DRUG

NOLVADEX (tamoxifen)DRUG

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

HoustonTexas, United States1 St LouisMissouri, United States1 ParisFrance1 PortlandOregon, United States1 MontrealQuebec, Canada1 AustinTexas, United States1 BudapestHungary1 PragueCzechia1 MarseilleFrance1 MontpellierFrance1 LyonFrance1 AlbuquerqueNew Mexico, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00232661 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.